Jakarta, 12 February 2022 – The Bakrie Center Foundation (BCF) entered a strategic partnership with the Global Health Security Consortium (GHSC) and Indonesia’s B20 in enhancing the country’s role in the global health agenda to create a global health legacy.
Founder of the philanthropic organisation BCF Anindya Bakrie stated that the foundation remains committed to encouraging a reform in the global health architecture to be more responsive in facing the current and future pandemics.
“BCF’s support, as a strategic partner, is part of the Bakrie Group’s commitment on their 80th anniversary in 2022 to initiate a 3C (climate, COVID-19, and capital trends) orientated corporation,” Bakrie stated in Jakarta on Saturday.
The GHSC, Indonesia’s B20, and BCF are collaborating to focus on the three key pillars that comprise expanding the global coverage of COVID-19 vaccine and other vaccines created to tackle infectious diseases, according to the organisation’s founder.
The second and third pillars would be to enhance the genomic sequencing-based early monitoring and early detection system to detect new variants and mutations of diseases as well as to bolster the partnership for research and investment in natural sciences between the global north and global south countries, he affirmed.
The collaboration, promoted throughout the G20 Summit under Indonesia’s Presidency, is consistent with BCF’s commitment to partnering with GHSC and Indonesia’s B20 in enhancing the global health architecture, Bakrie remarked.
“This is an essential factor to promote an inclusive and collaborative COVID-19 recovery globally,” he stressed.
The GHSC is an independent consortium of three major global health institutions, with expertise in the politics, science, and medical sectors that is led by former prime minister of the United Kingdom Sir Tony Blair.
The consortium comprises the Tony Blair Institute for Global Change, Lawrence J. Ellison Institute for Transformative Medicine, and a research team of Oxford University.